ASAPF (Aurora Spine) Accounts Payable & Accrued Expense: $2.54 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASAPF Aurora Spine Corp ASAPF
38 GF Score
Price $0.17
GF Value $0.25
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Aurora Spine Accounts Payable & Accrued Expense?

Aurora Spine ASAPF -2.73% 38 Accounts Payable & Accrued Expense is $2.54 Mil as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 38/100 and a GF Value™ of $0.25 (Possible Value Trap). The stock has 4 warning signs investors should review.

Aurora Spine's quarterly accounts payable & accrued expense declined from Sep. 2025 ($4.27 Mil) to Dec. 2025 ($2.97 Mil) and declined from Dec. 2025 ($2.97 Mil) to Mar. 2026 ($2.54 Mil).

Aurora Spine's annual accounts payable & accrued expense declined from Dec. 2023 ($3.01 Mil) to Dec. 2024 ($2.99 Mil) and declined from Dec. 2024 ($2.99 Mil) to Dec. 2025 ($2.97 Mil).


Aurora Spine Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Aurora Spine's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Spine Accounts Payable & Accrued Expense Chart

Aurora Spine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.45 2.83 3.01 2.99 2.97

Aurora Spine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 3.99 4.27 2.97 2.54
ASAPF
38GF Score
Aurora Spine Corp ASAPF
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Spine Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $2.54 Mil mean?
Aurora Spine (ASAPF) has a Accounts Payable & Accrued Expense of $2.54 Mil as of Mar. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Aurora Spine and its competitors.
Is Aurora Spine's Accounts Payable & Accrued Expense too high?
Aurora Spine's current Accounts Payable & Accrued Expense is $2.54 Mil. Overall, Aurora Spine has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Accounts Payable & Accrued Expense compare to ABT and SYK?
Aurora Spine's Accounts Payable & Accrued Expense of $2.54 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Medical Devices & Instruments company?
A good Accounts Payable & Accrued Expense depends on the Medical Devices & Instruments industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Aurora Spine and its competitors. Aurora Spine's current Accounts Payable & Accrued Expense is $2.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.17 — trading 33.6% below its estimated fair value. The current Accounts Payable & Accrued Expense is $2.54 Mil. Aurora Spine's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Accounts Payable & Accrued Expense is $2.54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (ASAPF) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of $0.17 is trading 33.6% below its estimated GF Value™ of $0.25. GuruFocus considers Aurora Spine to be Possible Value Trap.

Key valuation signals for ASAPF:

  • Accounts Payable & Accrued Expense: $2.54 Mil
  • GF Value™: $0.25 vs. price of $0.17 (33.6% below fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aurora Spine Business Description

Other Exchanges ASG:Canada
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
38GF Score

Get the complete analysis for ASAPF

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price
$0.25
GF Value